# NorthStar Medical closes $100 million financing with Oberland Capital

NorthStar Medical Technologies closed a $100 million secured financing with Oberland Capital to expand domestic Mo-99 radioisotope production capacity and implement RadioGenix System enhancements.

- Type: Investment
- Announced: 2019-04-23
- Where: United States
- Value: $100.0M
- Status: completed
- Products: molybdenum-99, technetium-99m, RadioGenix System
- Sectors: [Medical Devices](https://endata.com/sectors/medical-devices.md)

## Companies

- [NorthStar Medical Technologies](https://endata.com/companies/38907.md)
- [Oberland Capital Management](https://endata.com/companies/38908.md) (investor)

## Sources

- [biospace.com](https://www.biospace.com/northstar-medical-closes-100-million-financing-with-oberland-capital-to-expand-domestic-mo-99-radioisotope-production-capacity-and-implement-radiogenix-system-enhancements), 2019-04-23: "This financing agreement with Oberland Capital enables us to execute on our clearly defined strategy to build solid, sustainable momentum for NorthStar as a fully commercial enterprise."

---
Data from Endata (https://endata.com/). Announcements are summarized from public sources and may be incomplete; check the linked originals.